Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma()

Inhibition of the RAS-RAF-ERK-pathway using sorafenib as a first-line and regorafenib as a second-line treatment approach is the only effective therapeutic strategy for advanced hepatocellular carcinoma (HCC). Recent studies suggest that wild-type KRAS and HRAS isoforms could majorly contribute to H...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neoplasia
Asıl Yazarlar: Dietrich, Peter, Gaza, Anne, Wormser, Laura, Fritz, Valerie, Hellerbrand, Claus, Bosserhoff, Anja Katrin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Neoplasia Press 2019
Konular:
Original article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6370713/
https://ncbi.nlm.nih.gov/pubmed/30685691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2018.11.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller